| Previous close | 500.00 |
| Open | 500.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 300.00 |
| Expiry date | 2025-01-17 |
| Day's range | 500.00 - 500.00 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Yahoo FinanceEli Lilly reports $2 billion from Mounjaro, Zepbound in Q1 2024
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
- Thomson Reuters StreetEvents
Q1 2024 Eli Lilly and Co Earnings Call
Q1 2024 Eli Lilly and Co Earnings Call
- GuruFocus.com
Eli Lilly and Co (LLY) Q1 2024 Earnings Call Transcript Highlights: Stellar Growth and ...
Discover how Eli Lilly and Co (LLY) achieved impressive Q1 results and raised its 2024 outlook, driven by strong product performance and strategic expansions.
© 2024 Yahoo. All rights reserved.